BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2009
View Archived Issues
Tafluprost exhibits similar efficacy to latanoprost in phase II and III trials
Read More
Vitreosolve effective in clinical trials for PVD induction in diabetic retinopathy
Read More
Endoscopic trial in healthy subjects supports favorable efficacy of LT-NS001
Read More
FDA approves use of Diamyd vaccine in young children in TrialNet GAD diabetes study
Read More
Phase III program of TAK-085 in hypertriglyceridemia initiated in Japan
Read More
MRC reports results from international trial of PRO-2000 preventative HIV gel
Read More
Emend approved in Japan for chemotherapy-induced nausea and vomiting
Read More
ChemGenex and Hospira agree to codevelop omacetaxine for CML
Read More
ProMetic Life Sciences meets with FDA on regulatory pathway of PBI-1402
Read More
FDA approves Eli Lilly's Zyprexa Relprevv for schizophrenia in adults
Read More
Opexa Therapeutics reports securities offering to develop its MS therapy
Read More
Alcon to acquire Optonol
Read More
Data from phase II and III trials support efficacy of prucalopride in chronic constipation
Read More
GMI-1070 shows safety and tolerability in phase I trial in healthy subjects
Read More
Phase I data reported for terameprocol in patients with advanced leukemias
Read More
CALISTO trial reveals efficacy of fondaparinux in treating superficial vein thrombosis
Read More
Roche's ocrelizumab meets primary endpoint in phase III rheumatoid arthritis trial
Read More
TGen to test Nerviano Medical Sciences' new anticancer drug NMS-1286937
Read More
Pfizer presents FAAH inhibitors for the treatment of pain and other conditions
Read More
Vasopressin V1a receptor antagonists identified by sanofi-aventis
Read More
Takeda describes ASK1 inhibitors
Read More
Vertex describes PI3Kgamma kinase inhibitors for multiple sclerosis therapy
Read More
Novel ALK and Bcr-Abl inhibitors claimed by European scientists for cancer therapy
Read More
Kowa Pharmaceuticals divests diclofenac products Cambia and PRO-571
Read More
Qiagen closes acquisition of SABiosciences
Read More
BioAlliance's acyclovir Lauriad achieves endpoints in phase III trial
Read More
Ambit Biosciences initiates phase II trial of AC-220 in acute myeloid leukemia
Read More